Connect with us

News

Indian Council for Medical Research Fast-Tracks Roll Out Of Global COVID-19 ‘Solidarity’ Trial

‘Solidarity’ is an international clinical trial, launched by the World Health Organisation (WHO), to compare four treatment options against the standard of care to assess their relative effectiveness against COVID-19

Indian Council for Medical Research Fast-Tracks Roll Out Of Global COVID-19 ‘Solidarity’ Trial
Highlights
  • For the Solidarity trial, patients from multiple countries will be enrolled
  • The trial aims to discover if the drugs slow disease progression
  • The initiative aims to provide both speed and scale

New Delhi: The Indian Council for Medical Research (ICMR) has fast-tracked the roll out of the global ‘Solidarity’ trial launched by the World Health Organisation (WHO) to help in finding an effective treatment for COVID-19. ‘Solidarity’ is an international clinical trial to compare four treatment options against the standard of care to assess their relative effectiveness against COVID-19.

By enrolling patients in multiple countries, the trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Importantly, the initiative provides for both speed and scale.

Speaking about India’s participation, Prof Balram Bhargava, Secretary Department of Health Research and Director General, ICMR, said,

ICMR is working relentlessly to implement scientific interventions to combat the COVID-19 pandemic. The decision to join the WHO solidarity trial is an important step in this endeavour. The ICMR-National AIDS Research Institute (NARI) is the national coordination site for the trial in India. Four potential anti-viral agents, Remdesivir, Chloroquine/Hydroxychloroquine, Lopinavir-Ritonavir and Lopinavir-Ritonavir with Interferon (b1a) are to be evaluated in the trial, he added.

Also Read: Fight Against COVID-19: An Innovation To Make Masks And Protective Gear Reusable

We congratulate the central government, particularly ICMR for joining the global Solidarity trial. Through this collaboration, Indian researchers and institutions will participate in a global initiative to find effective treatment options for COVID-19. India plays a critical role in both research as well as in manufacturing once trials conclude successfully. WHO India is extending the required support to conduct the trial in India, Dr Henk Bekedam, WHO Representative to India, said.

The trial has begun recruiting COVID-19 patients in the country. Elaborating on the progress, Dr Sheela Godbole, senior scientist, NARI, and National Coordinator for the Solidarity trial in India said,

The required regulatory and ethical approvals have already been obtained and clinical trial sites have started to recruit patients in the trial.

Till now, a total of nine sites have been approved. The Solidarity trial provides simplified procedures to enable even overloaded hospitals to participate. Over 100 countries have requested participation to find effective therapeutics as soon as possible, via the trial.

Also Read: Unpredictable Effects Of Novel Coronavirus On Human Body Keep Doctors Baffled

The participation of multiple clinical trial units/hospitals in multiple countries will ensure adequate enrollment of participants in the shortest possible time. This will help fast-track the identification of correct treatment options for the COVID-19 disease.

World

24,20,23,922Cases
20,36,06,535Active
3,34,95,808Recovered
49,21,579Deaths
Coronavirus has spread to 195 countries. The total confirmed cases worldwide are 24,20,23,922 and 49,21,579 have died; 20,36,06,535 are active cases and 3,34,95,808 have recovered as on October 21, 2021 at 4:33 am.

India

3,41,27,450 18,454Cases
1,78,831 733Active
3,34,95,808 17,561Recovered
4,52,811 160Deaths
In India, there are 3,41,27,450 confirmed cases including 4,52,811 deaths. The number of active cases is 1,78,831 and 3,34,95,808 have recovered as on October 21, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

65,96,645 1,825

29,333 1,075

64,27,426 2,879

1,39,886 21

Kerala

48,79,790 11,150

83,333 2,476

47,69,373 8,592

27,084 82

Karnataka

29,84,484 462

9,103 26

29,37,405 479

37,976 9

Tamil Nadu

26,90,633 1,170

14,058 268

26,40,627 1,418

35,948 20

Andhra Pradesh

20,61,810 523

5,566 88

20,41,924 608

14,320 3

Uttar Pradesh

17,10,058 11

112 6

16,87,048 17

22,898

West Bengal

15,82,813 867

7,491 63

15,56,315 795

19,007 9

Delhi

14,39,466 25

310 12

14,14,066 37

25,090

Odisha

10,36,532 559

4,387 106

10,23,849 451

8,296 2

Chhattisgarh

10,05,735 34

185 3

9,91,979 36

13,571 1

Rajasthan

9,54,393 1

38 0

9,45,401 1

8,954

Gujarat

8,26,340 14

176 9

8,16,077 22

10,087 1

Madhya Pradesh

7,92,709 9

82 3

7,82,104 6

10,523

Haryana

7,71,116 15

133 7

7,60,934 8

10,049

Bihar

7,26,036 3

30 12

7,16,345 15

9,661

Telangana

6,69,556 191

3,968 28

6,61,646 162

3,942 1

Assam

6,07,427 308

3,610 25

5,97,859 282

5,958 1

Punjab

6,02,113 32

232 16

5,85,331 15

16,550 1

Jharkhand

3,48,486 25

142 14

3,43,209 11

5,135

Uttarakhand

3,43,773 8

176 1

3,36,199 6

7,398 1

Jammu And Kashmir

3,31,299 78

800 3

3,26,070 80

4,429 1

Himachal Pradesh

2,21,936 110

1,394 46

2,16,815 64

3,727

Goa

1,77,706 47

597 23

1,73,755 70

3,354

Puducherry

1,27,521 42

461 29

1,25,208 71

1,852

Manipur

1,22,970 71

1,360 2

1,19,706 66

1,904 3

Mizoram

1,15,207 741

10,263 505

1,04,548 1,243

396 3

Tripura

84,351 2

95 7

83,440 9

816

Meghalaya

83,158 79

761 21

80,958 58

1,439

Chandigarh

65,312 2

24 1

64,468 3

820

Arunachal Pradesh

55,043 12

138 7

54,625 19

280

Sikkim

31,800 17

175 6

31,232 22

393 1

Nagaland

31,659 18

255 8

30,728 10

676

Ladakh

20,886 3

34 0

20,644 3

208

Dadra And Nagar Haveli

10,676

2 2

10,670 2

4

Lakshadweep

10,365

0 0

10,314

51

Andaman And Nicobar Islands

7,646

7 1

7,510 1

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Highlights From The 12-Hour Telethon

Leaving No One Behind

Mental Health

Environment

Join Us